0001209191-21-028565.txt : 20210427
0001209191-21-028565.hdr.sgml : 20210427
20210427161851
ACCESSION NUMBER: 0001209191-21-028565
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210423
FILED AS OF DATE: 20210427
DATE AS OF CHANGE: 20210427
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Demski David M
CENTRAL INDEX KEY: 0001555392
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 21859174
MAIL ADDRESS:
STREET 1: C/O GLOBUS MEDICAL, INC.
STREET 2: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-23
0
0001237831
GLOBUS MEDICAL INC
GMED
0001555392
Demski David M
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
1
1
0
0
President, CEO
Class A Common Stock
2021-04-23
4
M
0
21875
43.77
A
21875
D
Class A Common Stock
2021-04-23
4
M
0
21875
43.58
A
43750
D
Class A Common Stock
2021-04-23
4
M
0
22821
29.31
A
66571
D
Class A Common Stock
2021-04-23
4
M
0
54688
53.27
A
121259
D
Class A Common Stock
2021-04-23
4
S
0
121259
71.59
D
0
D
Class A Common Stock
2021-04-26
4
M
0
78334
26.27
A
78334
D
Class A Common Stock
2021-04-26
4
M
0
65929
29.31
A
144263
D
Class A Common Stock
2021-04-26
4
S
0
144263
71.50
D
0
D
Stock Option (Right to Buy Class A Common Stock)
43.77
2021-04-23
4
M
0
21875
0.00
D
2028-01-22
Class A Common Stock
21875
28125
D
Stock Option (Right to Buy Class A Common Stock)
43.58
2021-04-23
4
M
0
21875
0.00
D
2029-01-22
Class A Common Stock
21875
65625
D
Stock Option (Right to Buy Class A Common Stock)
29.31
2021-04-23
4
M
0
22821
0.00
D
2027-08-28
Class A Common Stock
22821
97179
D
Stock Option (Right to Buy Class A Common Stock)
53.27
2021-04-23
4
M
0
54688
0.00
D
2030-01-22
Class A Common Stock
54688
120312
D
Stock Option (Right to Buy Class A Common Stock)
26.27
2021-04-26
4
M
0
78334
0.00
D
2027-01-30
Class A Common Stock
78334
0
D
Stock Option (Right to Buy Class A Common Stock)
29.31
2021-04-26
4
M
0
65929
0.00
D
2027-08-28
Class A Common Stock
65929
31250
D
This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.50 to $71.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.50 to $71.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on August 28, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on August 28, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
/s/ Kelly G. Huller, Attorney-in-Fact
2021-04-27